Let’s define three types of related research: life extension research (LER), ordinary biomedical research (OBR), and public health research (PHR).
In OBR, scientists induce specific diseases or injuries in model research organisms to study a causal pathway or treatment. In LER, they do not induce any specific disease.
I would also count a third path that we might call tool-making. Building better gene-sequencer is toolmaking. AlphaFold is toolmaking. CRISPR is toolmaking.
When looking at many problems in biology, those problems might not be solvable with the current toolkit and need the development of new tools to be solved.
I would also count a third path that we might call tool-making. Building better gene-sequencer is toolmaking. AlphaFold is toolmaking. CRISPR is toolmaking.
When looking at many problems in biology, those problems might not be solvable with the current toolkit and need the development of new tools to be solved.
I agree tools are important. I’m trying to define the difference between how LER/OBR/PHR go about using tools to improve health outcomes.